Evidence map›Paper›PMID 34086045›Full record

ArticleInvestigative ophthalmology & visual science2021

Sigma 1 Receptor Modulates Optic Nerve Head Astrocyte Reactivity.

Jing Zhao, Graydon Gonsalvez, Manuela Bartoli, Barbara A Mysona, Sylvia B Smith, Kathryn E Bollinger

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Considerations and implications of currentFrontiers in cell and developmental biology · 2025
    Review
  2. Article
  3. SIGMAR1 Confers Innate Resilience against Neurodegeneration.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jing ZhaoDepartment of Ophthalmology, Medical College of Georgia at Augusta University, Augusta, Georgia, United States.
Graydon GonsalvezDepartment of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University, Augusta, Georgia, United States.
Manuela BartoliDepartment of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University, Augusta, Georgia, United States.
Barbara A MysonaDepartment of Ophthalmology, Medical College of Georgia at Augusta University, Augusta, Georgia, United States.
Sylvia B SmithDepartment of Ophthalmology, Medical College of Georgia at Augusta University, Augusta, Georgia, United States.
Kathryn E BollingerDepartment of Ophthalmology, Medical College of Georgia at Augusta University, Augusta, Georgia, United States.
Augusta University · USDiscovery Institute · US

Funding

Module 3: Gene Expression/ProteomicsP30EY031631 · NEI · AUGUSTA UNIVERSITY · PI Xingjun Fan · 2020 to 2026
$3.6M
The Mechanism of Sigma 1 Receptor Mediated Neuroprotection in GlaucomaR01EY027406 · NEI · AUGUSTA UNIVERSITY · PI Kathryn Bollinger · 2018 to 2026
$3.2M
Sigma 1 Receptor: a novel therapeutic target for retinal degenerationR01EY028103 · NEI · AUGUSTA UNIVERSITY · PI SMITH, SYLVIA B. · 2017 to 2019
$1.2M
NEI NIH HHS P30 EY031631NEI NIH HHS R01 EY027406NEI NIH HHS R01 EY028103
6 · The paper itself

Abstract

Purpose: Stimulation of Sigma 1 Receptor (S1R) is neuroprotective in retina and optic nerve. S1R is expressed in both neurons and glia. The purpose of this work is to evaluate the ability of S1R to modulate reactivity responses of optic nerve head astrocytes (ONHAs) by investigating the extent to which S1R activation alters ONHA reactivity under conditions of ischemic cellular stress. Methods: Wild type (WT) and S1R knockout (KO) ONHAs were derived and treated with vehicle or S1R agonist, (+)-pentazocine ((+)-PTZ). Cells were subjected to six hours of oxygen glucose deprivation (OGD) followed by 18 hours of re-oxygenation (OGD/R). Astrocyte reactivity responses were measured. Molecules that regulate ONHA reactivity, signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappa B (NF-kB), were evaluated. Results: Baseline glial fibrillary acidic protein (GFAP) levels were increased in nonstressed KO ONHAs compared with WT cultures. Baseline cellular migration was also increased in nonstressed KO ONHAs compared with WT. Treatment with (+)-PTZ increased cellular migration in nonstressed WT ONHAs but not in KO ONHAs. Exposure of both WT and KO ONHAs to ischemia (OGD/R), increased GFAP levels and cellular proliferation. However, (+)-PTZ treatment of OGD/R-exposed ONHAs enhanced GFAP levels, cellular proliferation, and cellular migration in WT but not KO cultures. The (+)-PTZ treatment of WT ONHAs also enhanced the OGD/R-induced increase in cellular pSTAT3 levels. However, treatment of WT ONHAs with (+)-PTZ abrogated the OGD/R-induced rise in NF-kB(p65) activation. Conclusions: Under ischemic stress conditions, S1R activation enhanced ONHA reactivity characteristics. Future studies should address effects of these responses on RGC survival.

Indexed as

Optic DiskReceptors, sigmaAnimalsAstrocytesCells, CulturedMiceMice, KnockoutNeuroprotectionNeuroprotective AgentsOptic Neuropathy, IschemicPentazocineRetinal Ganglion CellsSigma-1 ReceptorTreatment OutcomeNeuroprotective AgentsPentazocineReceptors, sigmaSigma-1 Receptor

Identifiers

PMID34086045
PMCPMC8185400
OpenAlexW3164352212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.